API China 2026

Solutions in Pharmaceutical Manufacturing & Active Ingredients

With 22% world market share, annual growth rates exceeding 15%, annual output of 800,000 tons, and export turnover of US$600 million, China is the hot spot in the world bulk pharmaceutical market. API China, which focuses on bulk pharmaceuticals, fine chemicals & intermediates, excipients and drug formulation, pharmaceutical packaging material and machinery and food & cosmetic additives, attracts over 1,000 manufacturers, 1,500 APIs and intermediates and 26,000 professional visitors. With a 36,000 sqm exhibition area per edition, API has become a meeting place that cannot be missed.